PEBP1 and neoplasm: Based on the molecular context in which we find PEBP1 to be expressed, we postulate that a decrease in PEBP1 may be indicative of a skewing of the (DC-vaccine-triggered) immune response towards chronic inflammation/myeloid immune suppression rather than towards an effective anti-tumor response.